Bernie Sanders rejects Shkreli's campaign donation

Presidential hopeful Bernie Sanders (I-VT) has been slamming pharma on the campaign trail, and Turing Pharma CEO Martin Shkreli--who became the face of pharma's drug-price controversy after hiking the sticker on Daraprim by 5000%-plus--wants to talk it out. He donated $2,700 to Sanders' campaign--the max contribution for an individual--in late September in hopes of securing a meeting with Sanders, he told The Boston Globe. Sanders, though, isn't having it. Instead, the campaign will make a $2,700 donation to the Whitman-Walker health clinic in Washington, a spokesman told the paper. More

Suggested Articles

Last year at ESMO, AZ and Merck showed Lynparza topped its rivals at fending off prostate cancer. Now, Lynparza has helped patients live longer, too.

Merck and Eisai are trying to take their Keytruda-Lenvima combo into additional cancers, and new data provide a glimpse of where it might go next.

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.